Pharmaceutical Competitive Intelligence for the Regulatory Affairs Professional (SpringerBriefs in Pharmaceutical Science & Drug Development) - Image 1

£47.81

Springer Pharmaceutical Competitive Intelligence for the Regulatory Affairs Professional (SpringerBriefs in Pharmaceutical Science & Drug Development)

Name: Pharmaceutical Competitive Intelligence for the Regulatory Affairs Professional (SpringerBriefs in Pharmaceutical Science & Drug Development)
Brand: Springer
Price: 47.81 GBP
Availability: InStock

Allied Health Professions

It has never been this cheap. We have no record of a lower price.

£48 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 82 days • 82 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 82 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £49 (66 days, 80.5%)

Price range: £48 - £49

Price levels: 2 different prices over 82 days

Description

This Brief defines competitive intelligence (CI) as a tool for making investment decisions within the pharmaceutical industry. It provides an overview of processes that the regulatory affairs professional must take into account when evaluating data impacting product-based risk evaluations. These apply particularly to evaluations that focus on outputs such as regulatory approval, or the commercial impact of product labeling on the sales forecast over a limited timeframe. The Brief also provides an overview of intellectual property assessment that can impact a product’s lifespan on the market due to patent protection itself (or loss of patent protection) or via regulatory exclusivity. Case examples are discussed to illustrate the importance of keeping up with the ever-changing regulations, and how to interpret them in the context of CI. In addition, there is a section on virtual data rooms (VDRs) which currently function as the cornerstone of due diligence investigations. While aimed primarily at regulatory affairs professionals in the United States, this publication provides a useful adjunct for other pharmaceutical executives, especially those new to product-based investments, and regulatory affairs professionals in other regions.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 1461436818
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions
Domain: Amazon UK
Release Date: 07 June 2012
Listed Since: 16 February 2012

Barcode

No barcode data available

Springer Pharmaceutical Competitive Intelligence for the Regulatory Affairs Professional (SpringerBriefs in Pharmaceutical Science & Drug Development)

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

International Pharmaceutical Product Registration: 200 (Drugs and the Pharmaceutical Sciences)

Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)

Modern Strategy for Preclinical Pharmaceutical R&D: Towards the Virtual Research Company

Medical Product Regulatory Affairs: Pharmaceuticals, Diagnostics, Medical Devices

EU Law of Competition and Trade in the Pharmaceutical Sector (Elgar Competition Law and Practice series)

Springer - Intellectual Property Rights in Pharmaceutical Test Data

Optimization of Pharmaceutical R&D Programs and Portfolios: Design and Investment Strategy

Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World

Economics of Drug R&D:Financing, Strategic and Policy Considerations; Price Regulation,Capital Market Imperfections and Strategic R&D Investment Behavior in the Pharmaceutical Industry

Regulatory Protection in the Pharmaceutical and Life Science Industries: Challenges, Opportunities and Ongoing Reform (Elgar Monographs in Intellectual Property Law)

Regulatory Affairs in the Pharmaceutical Industry

Theory of Drug Development: 61 (Chapman & Hall/CRC Biostatistics Series)

Artificial Intelligence for Drug Product Lifecycle Applications

Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)

Software Innovations in Clinical Drug Development and Safety (Advances in Medical Technologies and Clinical Practice)

Global New Drug Development: An Introduction (ULLA Series in Pharmaceutical Sciences)

Research and Development in the Pharmaceutical Industry

Das europäische Arzneimittelrecht: Zentrale Rechtsfragen des Arzneimittelzulassungsverfahrens

EU Competition Law and Intellectual Property Rights (Elgar Competition Law and Practice series)

Fundamentals of Drug Development

CRC Press Clinical Drug Trials and Tribulations - Revised Edition

CRC Press Data Science, AI, and Machine Learning in Drug Development

Competition Law and Policy in the Japanese Pharmaceutical Sector (Kobe University Monograph Series in Social Science Research)

Economics of the Pharmaceutical and Medical Device Industry: Supply Chain, Trade and Innovation (Routledge Studies in the Economics of Innovation)